tiprankstipranks
Orchard Therapeutics PLC (DE:OT1A)
FRANKFURT:OT1A

Orchard Therapeutics (OT1A) Financial Statements

0 Followers

Orchard Therapeutics Financial Overview

Orchard Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Orchard Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ -8.68M$ 5.78M$ 4.37M$ 5.52M$ 483.00K
Gross Profit$ -6.78M$ 4.13M$ 3.25M$ 3.95M$ 483.00K
EBIT$ 133.80M$ -47.85M$ -50.46M$ -43.56M$ -35.54M
EBITDA$ 133.80M$ -47.20M$ -49.81M$ -42.85M$ -34.87M
Net Income Common Stockholders$ 134.89M$ -47.56M$ -50.92M$ -44.30M$ -36.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 143.75M$ 146.55M$ 170.89M$ 199.02M$ 220.11M
Total Assets$ 218.91M$ 234.05M$ 259.16M$ 291.50M$ 322.41M
Total Debt$ 58.09M$ 58.45M$ 59.89M$ 60.80M$ 59.48M
Net Debt$ -85.66M$ -88.10M$ -111.00M$ -138.22M$ -160.62M
Total Liabilities$ 120.64M$ 110.35M$ 112.89M$ 115.86M$ 112.46M
Stockholders Equity$ 98.26M$ 123.70M$ 146.27M$ 175.65M$ 209.95M
Cash Flow-
Free Cash Flow-$ -22.39M$ -27.55M$ -20.00M$ -33.79M
Operating Cash Flow-$ -17.93M$ -26.38M$ -19.60M$ -33.40M
Investing Cash Flow-$ 47.37M$ 19.64M$ 25.11M$ 14.76M
Financing Cash Flow-$ -19.00K$ 137.00K$ 0.00$ 150.00K
Currency in USD

Orchard Therapeutics Earnings and Revenue History

Orchard Therapeutics Debt to Assets

Orchard Therapeutics Cash Flow

Orchard Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis